tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

LVTX Stock Latest News

Lava Therapeutics doses first patient in Phase 1 LAVA-1266 study
The FlyLava Therapeutics doses first patient in Phase 1 LAVA-1266 study
21d ago
LVTX
LAVA Therapeutics to Transition to U.S. Domestic Issuer
PremiumCompany Announcements
LAVA Therapeutics to Transition to U.S. Domestic Issuer
29d ago
8K
LVTX
Lava Therapeutics price target lowered to $2 from $6 at H.C. Wainwright
PremiumThe Fly
Lava Therapeutics price target lowered to $2 from $6 at H.C. Wainwright
1M ago
LVTX
Lava Therapeutics downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Lava Therapeutics downgraded to Market Perform from Outperform at Leerink
2M ago
LVTX
Lava Therapeutics downgraded to Market Perform from Outperform at JMP
PremiumThe Fly
Lava Therapeutics downgraded to Market Perform from Outperform at JMP
2M ago
LVTX
LAVA Therapeutics Reports Increased Losses Amid Declining Revenues
PremiumCompany AnnouncementsLAVA Therapeutics Reports Increased Losses Amid Declining Revenues
2M ago
6K
LVTX
Lava Therapeutics reports Q3 EPS (46c) vs (34c) last year
Premium
The Fly
Lava Therapeutics reports Q3 EPS (46c) vs (34c) last year
2M ago
LVTX
LVTX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
LVTX Upcoming Earnings Report: What to Expect?
3M ago
LVTX
LAVA Therapeutics Faces Financial Hurdles
PremiumCompany Announcements
LAVA Therapeutics Faces Financial Hurdles
5M ago
6K
LVTX
Lava Therapeutics reports Q2 EPS (31c) vs (48c) last year
PremiumThe Fly
Lava Therapeutics reports Q2 EPS (31c) vs (48c) last year
5M ago
LVTX
Is LVTX a Buy, Before Earnings?
PremiumPre-Earnings
Is LVTX a Buy, Before Earnings?
6M ago
LVTX
LAVA Therapeutics Shareholders Approve Key Resolutions
PremiumCompany Announcements
LAVA Therapeutics Shareholders Approve Key Resolutions
7M ago
6K
LVTX
LAVA Therapeutics’ Innovative Gammabody® Cancer Therapy
PremiumCompany AnnouncementsLAVA Therapeutics’ Innovative Gammabody® Cancer Therapy
8M ago
6K
LVTX
LAVA Therapeutics Narrows Losses, Grows Profit
Premium
Company Announcements
LAVA Therapeutics Narrows Losses, Grows Profit
8M ago
6K
LVTX
Lava Therapeutics reports Q1 EPS (2c) vs (53c) last year
Premium
The Fly
Lava Therapeutics reports Q1 EPS (2c) vs (53c) last year
9M ago
LVTX
LVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
LVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
9M ago
LVTX
LAVA Therapeutics Announces Progress and Stability
PremiumCompany Announcements
LAVA Therapeutics Announces Progress and Stability
11M ago
6K
LVTX
Lava Therapeutics reports Q4 EPS (24c), consensus (12c)
PremiumThe Fly
Lava Therapeutics reports Q4 EPS (24c), consensus (12c)
11M ago
LVTX
LVTX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
LVTX Upcoming Earnings Report: What to Expect?
11M ago
LVTX
Lava Therapeutics announces clinical development milestone achieved by Pfizer
PremiumThe FlyLava Therapeutics announces clinical development milestone achieved by Pfizer
11M ago
PFE
LVTX
Lava enters collaboration with Merk to evaluate LAVA-1207, KEYTRUDA
Premium
The Fly
Lava enters collaboration with Merk to evaluate LAVA-1207, KEYTRUDA
1y ago
MRK
LVTX
Lava Therapeutics reports Q3 EPS (34c), consensus (49c)
Premium
The Fly
Lava Therapeutics reports Q3 EPS (34c), consensus (49c)
1y ago
LVTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >